Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Dynavax Technologies shares drop as the company files FDA response over hepatitis B drug
Dynavax Technologies shares drop as the company files FDA response over hepatitis B drug
Dynavax Technologies shares drop as the company files FDA response over hepatitis B drug
Submitted by
admin
on September 19, 2008 - 8:48am
Source:
Yahoo/AP
Headline:
Dynavax Technologies shares drop as the company files FDA response over hepatitis B drug
Do Not Allow Advertisers to Use My Personal information
